Price (delayed)
$108.17
Market cap
$7.51B
P/E Ratio
17.31
Dividend/share
N/A
EPS
$6.25
Enterprise value
$7.32B
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging
There are no recent dividends present for LNTH.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.